This protocol is judged by an institutional overview board, an impartial group that assessments any scientific trials involving people. If a review consists of a Schedule I drug, after the board approves the protocol as moral, the researchers really need to submit an application for an investigational new drug (IND) quantity with the FDA.Fortunate